Free Health Updates
Skip to main content
Table of Contents
< All Topics
Print

Can Families TravelĀ withĀ CannabisĀ forĀ Dementia Care?Ā 

Posted
Updated
ByMy Patient Advice
Author: Julia Sutton, MSc | Reviewed by: Dr. Clarissa Morton, PharmD

As medical cannabis use grows in the UK, some families caring for loved ones with dementia wonder whether they can legally travel with prescribed cannabis. The answer depends on where they are travelling, the type of product prescribed, and whether the medicineĀ complies withĀ UK and internationalĀ controlled-drugĀ regulations.Ā 

Can medical cannabis be accessed legally for womenā€™s health?

Cannabis and UK Travel Law 

Cannabis-based medicinal products (CBPMs) are legal in the UK only when prescribed by a specialist doctor registered with the General Medical Council (GMC) and dispensed by a licensed pharmacy. These medicines are classed as Schedule 2 controlled drugs under the Misuse of Drugs Regulations 2001 (UK Legislation). 

According to NHS England, patients travelling within the UK may carry their prescribed cannabis medicine only if it remains in its original packaging, with the pharmacy label clearly visible. They must also carry a copy of the prescription and, ideally, a letter from the prescribing doctor confirming the medical necessity of the treatment. 

However, dementia is not one of the approved conditions for cannabis treatment under NICE guidance (NG97), so travel with cannabis for dementia would only apply to off-label prescriptions. 

Travelling Abroad with Cannabis 

The Home Office advises anyone travelling abroad with a controlled drug to apply for a Home Office export licence if carrying more than a three-month supply. Each destination country may also require import authorisation before entry. Without the appropriate paperwork, travellers risk confiscation, fines, or prosecution at customs. 

Some nations, such as Canada or Germany, allow medical cannabis use under strict regulations, while others ban it entirely. 

Practical and Ethical Considerations 

If a person with dementia is prescribed cannabis for symptom management, family members or carers should ensure: 

  • The prescription is active and clearlyĀ labelled.Ā 
  • All documents (prescription, export licence, and doctorā€™s letter) are carried.Ā 
  • The medicine is declared at customs if requested.Ā 
  • The personā€™sĀ capacity to consentĀ to treatment has been assessed in line with theĀ Mental Capacity Act 2005Ā (UK Legislation).Ā 

Clinical Bottom Line 

  • Travelling within the UK with prescribed cannabis is legal if documentation is complete.Ā 
  • International travel requires Home Office export authorisation and destination-country approval.Ā 
  • Dementia isĀ not an approved conditionĀ for cannabis prescriptions under UK law.Ā 
  • Families must verify all legal and medical requirements beforeĀ travelling.Ā 

Educational Context: AlleviMed 

AlleviMed provides educational resources on UK cannabis regulation and safe patient travel with controlled medicines. It helps families understand export licensing, storage rules, and documentation standards for legal compliance. 

Takeaway 

Families can travel with cannabis prescribed for dementia only under strict legal authorisation. Within the UK, prescriptions must remain in original packaging with clear documentation. For international travel, Home Office approval and local import permissions are essential. Without them, carrying cannabis across borders remains a criminal offence, even for medical use. 

Julia Sutton, MSc
Author

Julia Sutton is a clinical psychologist with a Masterā€™s in Clinical Psychology and experience providing psychological assessment and therapy to adolescents and adults. Skilled in CBT, client-centered therapy, and evidence-based interventions, she has worked with conditions including depression, anxiety, bipolar disorder, and conversion disorder. She also has experience in child psychology, conducting psycho-educational evaluations and developing tailored treatment plans to improve learning and well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy.Ā 

Dr. Clarissa Morton, PharmD
Reviewer

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewers's privacy.Ā 

Categories